Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples